Robeauté
PrivateLast Round
Seed
Jan 14, 2025
Total Funding Raised
$39.35M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Robeauté operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Seed round in January 2025.
Robeauté is a medtech company that develops therapeutic microrobots for neurosurgery to diagnose, treat, and monitor neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Industrial Robotics, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Robeauté Comparables
Compare Robeauté with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Panda Surgical | 83% | |
| AiM Medical Robotics | 79% | |
| Zeta Surgical | 78% |
For institutional investors. Book with your work email.
Robeauté Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 14, 2025 | ||||
| Grant | Nov 13, 2023 | ||||
| Seed | Jan 14, 2022 | ||||
| Grant | Jun 2, 2020 | ||||
| Grant | Jul 4, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Robeauté Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Think.Health | Seed |
| Région Île-de-France | Grant |
| European Innovation Council Fund | Grant |
| LocalGlobe | Seed |
| Urania Ventures | Seed |
| Kindred Ventures | Seed |
| EIT Health | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Developing a second clinical product for drug delivery, named DOT.DRUG.
- Jul 26, 2026
Monthly visitors grew 151% MoM, from 2.4K to 5.9K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 9, 2026
Robeaute is developing its neurosurgical microrobot platform in France after raising $28 million in Jan '25, with tissue sampling for brain biopsies as its first proposed application and human trials targeted for 2026.
For institutional investors. Book with your work email.
Robeauté Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Robeauté's valuation, stock price, and market status.
Is Robeauté a public or private company?
Robeauté is a private company.
What is the current stock price of Robeauté?
Robeauté is a private company, so its shares have no public market price. Caplight tracks Robeauté's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Robeauté worth (valuation)?
Valuation information for Robeauté is not publicly available.
Can I buy Robeauté stock?
Robeauté shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Robeauté's last funding round?
Robeauté's most recent funding round was Seed on January 14, 2025.
Who are the main investors in Robeauté?
Key investors in Robeauté include Kindred Ventures, APEX Ventures, Plural, Plural, Cherry Ventures.
Will Robeauté IPO soon?
No public IPO plans have been announced for Robeauté.
How can I track Robeauté secondary market activity?
Caplight tracks bids, offers, and trades in Robeauté's shares on secondary markets.